Innate Pharma S.A. (EPA:IPH)
France · Delayed Price · Currency is EUR 1.316
-0.034 (-2.52%)
Oct 2, 2026, 5:35 PM CET
Innate Pharma Employees
Innate Pharma had 120 employees as of June 30, 2026. The number of employees decreased by 44 or -26.83% since the number was reported on December 31, 2025.
Employees
120
Change
-44
Growth
-26.83%
Revenue / Employee
€81,733
Profits / Employee
€395,467
Market Cap
126.50M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 120 | -44 | -26.83% |
| Dec 31, 2025 | 164 | -17 | -9.39% |
| Dec 31, 2024 | 181 | 2 | 1.12% |
| Dec 31, 2023 | 179 | -32 | -15.17% |
| Dec 31, 2022 | 211 | -4 | -1.86% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Valneva SE | 620 |
| Cellectis | 229 |
| Genfit | 161 |
| Transgene | 145 |
| Adocia | 73 |
| Sensorion | 66 |
| OSE Immunotherapeutics | 64 |
| Fermentalg | 64 |
Innate Pharma News
- 15 hours ago - Innate Pharma S.A. - Depositary Receipt Price Target Increased by 27.91% to $8.22 - Nasdaq
- 15 days ago - Innate Pharma (IPHA) Q2 2026 Earnings Call Transcript - The Motley Fool
- 15 days ago - Innate Pharma Q2 Earnings Call Highlights - MarketBeat
- 15 days ago - Innate Pharma Earnings Call Transcript: Q2 2026 - Transcripts
- 15 days ago - Innate Pharma Earnings release: Q2 2026 - Filings
- 15 days ago - Innate Pharma Earnings release: Q2 2026 - Filings
- 15 days ago - Innate Pharma Quarterly report: Q2 2026 - Filings
- 15 days ago - Innate Pharma Slides: Q2 2026 - Filings